background: acute coronary syndrome is a life-threatening condition. considerable doubts exist over the effects of this disease on patients’ quality of life. the aim of this study was to survey quality of life and its influencing factors in patients with acute coronary syndrome. methods: a convenience sample of 300 patients with acute coronary syndrome was drawn from shahid beheshti hospital, k...

UNLABELLED INTRODUCTION Spontaneous coronary artery dissection is an important yet rare cause of acute coronary syndrome. The available literature shows a higher risk factor for women, notably during pregnancy and puerperium. The incidence in postmenopausal women is exceedingly rare, and is more commonly seen in association with concurrent predisposing factors.We illustrate an extremely rare...

INTRODUCTION AND OBJECTIVES There is little information on the effect of acute coronary syndrome complicated by ventricular fibrillation on the long-term incidence of sudden cardiac death. We analyzed this effect in a contemporary cohort of patients with acute coronary syndrome. METHODS We studied 5302 consecutive patients with acute coronary syndrome between December 2003 and December 2012. ...

BACKGROUND Brazil lacks published multicenter registries of acute coronary syndrome. OBJECTIVE The Brazilian Registry of Acute Coronary Syndrome is a multicenter national study aiming at providing data on clinical aspects, management and hospital outcomes of acute coronary syndrome in our country. METHODS A total of 23 hospitals from 14 cities, participated in this study. Eligible patients ...

103 The Editor, A 27‐year‐old male professional bodybuilder presented with excruciating retrosternal chest pain, extending to his neck and shoulder. He gave a history of taking traditional medication (containing opium) for the pain that was self‐prescribed but the pain did not subside with that treatment, and his general physician referred him for cardiac evaluation in the emergency department....

placebo group but not in the atorvastatin group. Compared with placebo, atorvastatin reduced median sPLA2 mass ( 32.1% versus 23.1%), sPLA2 activity ( 29.5% versus 19.2%), Lp-PLA2 mass ( 35.8% versus 6.2%), and Lp-PLA2 activity ( 24.3% versus 5.4%; P 0.001 for all). Atorvastatin reduced the hazard of death associated with elevated sPLA2 mass and activity by 50%. Conclusions—sPLA2 mass independe...

Spontaneous coronary artery dissection (SCAD) is an uncommon cause of acute coronary syndrome which may be related to lethal condition. Although several modalities including medical therapy have been suggested, agreement on optimal treatment has not yet been determined. We describe a case of SCAD which was presented as ST-segment elevation myocardial infarction, and treated successfully with me...